Management of Electrolyte Imbalances

Indications and Mechanism of Action

• DDAVP increases water reabsorption in the kidneys, beneficial in conditions with excessive water loss, such as central diabetes insipidus, but not in most cases of hypernatremia with other etiologies, as recommended by the American College of Nephrology 1
• Desmopressin is used for hemostatic purposes in certain bleeding disorders, with recommended dosing regimens including 0.3-0.4 mcg/kg infused over 30 minutes for patients with bleeding or requiring surgery, supported by the American Academy of Child and Adolescent Psychiatry, American Heart Association, and American Urological Association 2, 3, 4

Monitoring and Safety Precautions

• Serum sodium levels should be monitored closely in patients receiving oxytocin or desmopressin, with checks within 24 hours of oxytocin administration and continued monitoring for at least 72 hours after oxytocin discontinuation, and within 1 week and approximately 1 month after starting desmopressin therapy, then periodically, as recommended by the American Urological Association and American Association for the Study of Liver Diseases 5, 6
• The following table summarizes the recommended sodium correction limits for high-risk and average-risk patients:

• High-risk patients, including those with cirrhosis, alcoholism, malnutrition, severe hyponatremia, hypophosphatemia, hypokalemia, hypoglycemia, low cholesterol, or prior encephalopathy, should have sodium correction limited to 4-6 mEq/L per 24 hours, not exceeding 8 mEq/L per 24 hours, while average-risk patients should have sodium correction limited to 4-8 mEq/L per 24 hours, not exceeding 10-12 mEq/L per 24 hours 5

Patient Education and Adverse Effects

• Patients should limit evening fluid intake to 200 ml or less with no drinking until morning to minimize the risk of hyponatremia, and desmopressin is not indicated for patients with factor VIII levels ≤5% or for patients with factor VIII antibodies, with caution exercised in patients with moderate to severe renal impairment, hyponatremia, or history of hyponatremia 2, 4, 6
• Common adverse effects of desmopressin include fluid-related complications, such as oliguria, hypervolemia, and hyponatremia, as well as systemic vasodilator effects, such as arterial hypotension, reactive tachycardia, and facial flushing, with rare thromboembolic events reported, as suggested by the European Society of Endocrinology 7, 8
• Patients should be educated on the importance of monitoring serum sodium levels and limiting fluid intake to minimize the risk of hyponatremia, with guidance on recognizing signs and symptoms of hyponatremia and seeking medical attention if necessary, as supported by the American Academy of Child and Adolescent Psychiatry and American Heart Association 2, 6